Clin2
NCT07830654Likely a fitRecruiting

Pet scan for Parkinson's disease

Parkinson's Disease (PD)Healthy Control Subjects

Part of Brain & nervous system clinical trials.

This study tests a new PET scan tracer called [18F]AV-133 to see if it can track Parkinson's disease over time. The scan may help doctors better understand the disease, and you would be part of the PPMI research program.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
50 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 or older and have been diagnosed with Parkinson's disease, or you are a healthy volunteer in the PPMI study.
  • You are willing and able to give informed consent.
  • If you are female, you must either be unable to become pregnant (postmenopausal or surgically sterile) or use a highly effective birth control method while in the study and for at least 14 days before the scan.
  • If you are female, you must not be pregnant or breastfeeding.
  • You have not taken certain medications (like tetrabenazine, methylphenidate, reserpine, or an amphetamine derivative) within the last month.
  • Your health must not otherwise prevent you from taking part in the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06891703Recruiting· Early Phase 1
PET imaging study for Parkinson's and related conditions

This trial uses a new imaging agent (like a dye) to see signs of Parkinson's disease in the brain. If you have Parkinson's or a related condition like Lewy body dementia or multiple system atrophy, this scan may help researchers better understand these illnesses.

Solna
NCT07265596Recruiting· Phase 2
Brain Scan Study for Early Parkinson's Disease

This trial uses a special brain scan (PET scan) to look at early changes in people who have early signs of Parkinson's disease. The goal is to learn more about how Parkinson's develops over time.

New Haven, Connecticut
NCT07809438Recruiting· Phase 2
Comparing PET scans for early Parkinson's detection

This study tests two different PET scan resolutions to see which is better at detecting signs of early Parkinson's. It is for people who are already part of a Parkinson's research study and may help improve early diagnosis.

New Haven, Connecticut
NCT07020026Recruiting· Phase 2
Tau brain scan study for Parkinson's and related disorders

This study uses a special PET scan to measure tau protein buildup in the brain of people with Parkinson's disease (including those with a LRRK2 gene mutation), Progressive Supranuclear Palsy, or Corticobasal Syndrome. It aims to better understand how tau relates to these conditions.

New Haven, Connecticut
NCT06098612Recruiting· Early Phase 1
PET imaging study for Parkinson's and related disorders

This study uses a new PET scan tracer called [11C]SY08 to take pictures of the brain in people with Parkinson's, multiple system atrophy, or dementia with Lewy bodies. It aims to see if this tracer can help better understand and tell apart these conditions.

Charlestown, Massachusetts
NCT07640555Recruiting· Early Phase 1
Brain imaging study for Parkinson's and related movement disorders

This research study tests a new type of brain scan (called a PET scan) that may help detect early signs of Parkinson's disease and similar conditions. You'll receive the scan and may have a spinal tap to check for specific protein markers.

New Haven, Connecticut

Hear when a new Parkinson's Disease (PD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.